Prof. Jungmok Seo’s research team (BLISS) has introduced a new type of organ-on-a-chip to minimize the unintended adsorption of drugs. This technology has significantly improved the sensitivity of drug screening in the preclinical stage of drug development.

The results were approved for publication in Small (IF=13.0). This study was supervised by Professor Jungmok Seo (corresponding author) and led by Tae Young Kim, the first author.